Skip to main content
Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · IEX Real-Time Price · USD
1.300
+0.580 (80.56%)
At close: Apr 26, 2024, 4:00 PM
1.170
-0.130 (-10.00%)
After-hours: Apr 26, 2024, 6:09 PM EDT

Biodexa Pharmaceuticals Revenue

In the year 2023, Biodexa Pharmaceuticals had annual revenue of $482.28K, a decrease of -42.73%.

Revenue (ttm)
$482.28K
Revenue Growth
-42.73%
P/S Ratio
0.59
Revenue / Employee
$22,966
Employees
21
Market Cap
307.46K USD

Revenue Chart

* The company reports in GBP currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023482.28K-359.89K-42.73%
Dec 31, 2022842.17K71.50K9.28%
Dec 31, 2021770.67K300.80K64.02%
Dec 31, 2020469.86K-416.98K-47.02%
Dec 31, 2019886.84K-1.57M-63.94%
Dec 31, 20182.46M1.12M84.07%
Dec 31, 20171.34M-297.81K-18.23%
Dec 31, 20161.63M-393.11K-19.39%
Dec 31, 20152.03M1.78M728.72%
Dec 31, 2014244.60K1.15K0.47%
Dec 31, 2013243.45K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

BDRX News

More News